It’s not unusual for stocks in the diabetes sector to rise during ADA, even when this year ADA was a virtual event. ADA is one of the few times of the year when the sector receives a heightened amount of attention. Yet this heightened attention does not explain the incredible rise in Livongo. Over the past three months shares in the company have risen an astonishing 230%. Back on April 17th shares closed at $37.30, yesterday shares closed at $66.52 and up more in pre-market trading today.
The company now carries a market cap . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.